vs
Marathon Bancorp, Inc.（MBBC）与Roivant Sciences Ltd.（ROIV）财务数据对比。点击上方公司名可切换其他公司
Marathon Bancorp, Inc.的季度营收约是Roivant Sciences Ltd.的1.1倍（$2.2M vs $2.0M），Marathon Bancorp, Inc.净利率更高（22.3% vs -13301.2%，领先13323.5%），Marathon Bancorp, Inc.同比增速更快（41.7% vs -77.8%），Marathon Bancorp, Inc.自由现金流更多（$1.4M vs $-201.4M），过去两年Marathon Bancorp, Inc.的营收复合增速更高（20.3% vs -73.7%）
Marathon Bancorp, Inc.是总部位于美国马里兰州的金融控股公司，旗下运营社区银行子公司，面向马里兰州本地个人及中小企业客户提供存款账户、消费贷款、商业抵押贷款、小微企业融资等全品类零售及商业银行服务。
Roivant Sciences Ltd.是一家美国跨国医疗健康企业，2014年由维韦克·拉马斯瓦米创立，现任CEO为马特·格林。公司专注于将技术应用于药物研发领域，同时孵化运营多家生命科学与健康科技子公司，总部位于纽约，在波士顿、巴塞尔两大生物科技产业集群也设有核心办公点。
MBBC vs ROIV — 直观对比
营收规模更大
MBBC
是对方的1.1倍
$2.0M
营收增速更快
MBBC
高出119.5%
-77.8%
净利率更高
MBBC
高出13323.5%
-13301.2%
自由现金流更多
MBBC
多$202.8M
$-201.4M
两年增速更快
MBBC
近两年复合增速
-73.7%
损益表 — Q2 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.2M | $2.0M |
| 净利润 | $501.4K | $-265.9M |
| 毛利率 | — | — |
| 营业利润率 | 26.2% | -16966.1% |
| 净利率 | 22.3% | -13301.2% |
| 营收同比 | 41.7% | -77.8% |
| 净利润同比 | 880.7% | -257.0% |
| 每股收益（稀释后） | $0.19 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MBBCROIV
| Q4 25 | $2.2M | $2.0M | ||
| Q3 25 | $2.1M | $1.6M | ||
| Q2 25 | $1.9M | $2.2M | ||
| Q1 25 | $1.7M | $-39.6M | ||
| Q4 24 | $1.6M | $9.0M | ||
| Q3 24 | $1.6M | $4.5M | ||
| Q2 24 | $1.6M | $8.0M | ||
| Q1 24 | $1.6M | $28.9M |
净利润MBBCROIV
| Q4 25 | $501.4K | $-265.9M | ||
| Q3 25 | $444.3K | $-113.5M | ||
| Q2 25 | $-332.0K | $-223.4M | ||
| Q1 25 | $148.4K | $-206.5M | ||
| Q4 24 | $51.1K | $169.4M | ||
| Q3 24 | $174.9K | $-230.2M | ||
| Q2 24 | $85.8K | $95.3M | ||
| Q1 24 | $-631.1K | $-151.1M |
营业利润率MBBCROIV
| Q4 25 | 26.2% | -16966.1% | ||
| Q3 25 | 25.5% | -19492.9% | ||
| Q2 25 | -25.7% | -13130.0% | ||
| Q1 25 | 11.6% | 674.8% | ||
| Q4 24 | 3.3% | -3042.6% | ||
| Q3 24 | 13.4% | -7636.0% | ||
| Q2 24 | 4.1% | -1279.5% | ||
| Q1 24 | -53.7% | -919.5% |
净利率MBBCROIV
| Q4 25 | 22.3% | -13301.2% | ||
| Q3 25 | 20.7% | -7225.9% | ||
| Q2 25 | -18.9% | -10292.9% | ||
| Q1 25 | 8.9% | 521.8% | ||
| Q4 24 | 3.2% | 1878.3% | ||
| Q3 24 | 10.8% | -5143.8% | ||
| Q2 24 | 6.2% | 1192.7% | ||
| Q1 24 | -40.7% | -522.3% |
每股收益（稀释后）MBBCROIV
| Q4 25 | $0.19 | $-0.38 | ||
| Q3 25 | $0.17 | $-0.17 | ||
| Q2 25 | $-0.13 | $-0.33 | ||
| Q1 25 | $0.07 | $-0.28 | ||
| Q4 24 | $0.02 | $0.23 | ||
| Q3 24 | $0.06 | $-0.31 | ||
| Q2 24 | $0.07 | $0.12 | ||
| Q1 24 | $-0.31 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $4.5B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $46.9M | $4.3B |
| 总资产 | $248.0M | $5.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MBBCROIV
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.9B | ||
| Q4 24 | — | $5.1B | ||
| Q3 24 | — | $5.4B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $6.5B |
总债务MBBCROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $311.7M | ||
| Q1 24 | — | $430.6M |
股东权益MBBCROIV
| Q4 25 | $46.9M | $4.3B | ||
| Q3 25 | $46.3M | $4.4B | ||
| Q2 25 | $45.7M | $4.3B | ||
| Q1 25 | $32.0M | $4.7B | ||
| Q4 24 | $31.7M | $5.2B | ||
| Q3 24 | $31.6M | $5.2B | ||
| Q2 24 | $31.3M | $5.4B | ||
| Q1 24 | $31.4M | $6.0B |
总资产MBBCROIV
| Q4 25 | $248.0M | $5.2B | ||
| Q3 25 | $246.0M | $5.1B | ||
| Q2 25 | $238.8M | $5.0B | ||
| Q1 25 | $236.8M | $5.4B | ||
| Q4 24 | $217.9M | $5.8B | ||
| Q3 24 | $216.5M | $6.2B | ||
| Q2 24 | $219.3M | $6.5B | ||
| Q1 24 | $225.8M | $7.2B |
负债/权益比MBBCROIV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.4M | $-196.5M |
| 自由现金流经营现金流 - 资本支出 | $1.4M | $-201.4M |
| 自由现金流率自由现金流/营收 | 62.3% | -10076.0% |
| 资本支出强度资本支出/营收 | 0.6% | 246.9% |
| 现金转化率经营现金流/净利润 | 2.82× | — |
| 过去12个月自由现金流最近4个季度 | $3.9M | $-776.7M |
8季度趋势，按日历期对齐
经营现金流MBBCROIV
| Q4 25 | $1.4M | $-196.5M | ||
| Q3 25 | $464.0K | $-185.7M | ||
| Q2 25 | $1.4M | $-204.4M | ||
| Q1 25 | $849.0K | $-172.6M | ||
| Q4 24 | $113.6K | $-207.3M | ||
| Q3 24 | $945.2K | $-266.8M | ||
| Q2 24 | $416.6K | $-192.8M | ||
| Q1 24 | $-802.1K | $-108.5M |
自由现金流MBBCROIV
| Q4 25 | $1.4M | $-201.4M | ||
| Q3 25 | $456.6K | $-193.5M | ||
| Q2 25 | $1.3M | $-208.4M | ||
| Q1 25 | $773.2K | $-173.4M | ||
| Q4 24 | $105.0K | $-209.1M | ||
| Q3 24 | $921.6K | $-267.8M | ||
| Q2 24 | $-1.8M | $-193.8M | ||
| Q1 24 | $-1.1M | $-108.8M |
自由现金流率MBBCROIV
| Q4 25 | 62.3% | -10076.0% | ||
| Q3 25 | 21.3% | -12317.8% | ||
| Q2 25 | 66.0% | -9604.5% | ||
| Q1 25 | 46.3% | 438.1% | ||
| Q4 24 | 6.6% | -2318.5% | ||
| Q3 24 | 57.1% | -5984.4% | ||
| Q2 24 | -118.5% | -2425.5% | ||
| Q1 24 | -67.9% | -376.1% |
资本支出强度MBBCROIV
| Q4 25 | 0.6% | 246.9% | ||
| Q3 25 | 0.3% | 499.6% | ||
| Q2 25 | 9.3% | 185.9% | ||
| Q1 25 | 4.5% | -2.0% | ||
| Q4 24 | 0.5% | 20.3% | ||
| Q3 24 | 1.5% | 22.3% | ||
| Q2 24 | 145.2% | 12.1% | ||
| Q1 24 | 16.2% | 1.2% |
现金转化率MBBCROIV
| Q4 25 | 2.82× | — | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 5.72× | — | ||
| Q4 24 | 2.22× | -1.22× | ||
| Q3 24 | 5.40× | — | ||
| Q2 24 | 4.85× | -2.02× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
